Skip to main content
Clinical Trials/NL-OMON29157
NL-OMON29157
Recruiting
Not Applicable

A PROspective, explorative cohort study to correlate CARdiac BIomarkers with late cardiac toxicity induced by radiotherapy alone or combined with anthracycline chemotherapy for hodgkin lymphoma (PROCARBI)

Department of radiotherapy and cardiology of Erasmus MC0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of radiotherapy and cardiology of Erasmus MC
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Department of radiotherapy and cardiology of Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • Previous history of Hodgkin or mediastinal non\-Hodgkin lymphoma treated with mediastinal radiotherapy with or without anthracycline\-containing chemotherapy
  • Planned visit at the BETER clinic
  • Written informed consent
  • Age \>\= 18 years
  • A minimum of 5 years of disease free survival

Exclusion Criteria

  • Not currently under treatment for malignant disease (unless basal cell carcinoma).
  • Patients who already underwent a surgical intervention for cardiac problems, such as heart valve replacement or a coronary artery bypass grafting (CABG).

Outcomes

Primary Outcomes

Not specified

Similar Trials